Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • TimK
    Member
    • Jul 2014
    • 13

    New to TruSeq: does this look good?

    Hi,
    I am trying to do some DE-analysis with different TruSeq paired-end samples. As I'm new to RNA-Seq I'd like to ask for some advice/opinions on my data and my quality control settings.

    I use fastqc for quality control and none of my samples look as 'nice' as I'd expect it to be if it was a metagenomic sample: among others, GC-content, overrepresented sequences and
    per base sequence content get warnings in all samples. Also, processing has almost no effect on the quality.
    I am aware that the fastqc output of RNA-Seq data differs from metagenomic data. For example, I'd expect bias in the overrepresented sequences due to different expression levels of
    genes etc. However, I'd like to get that confirmed by someone more experienced than me to know that I'm not on the wrong track here.

    This is the fastqc plots for one sample before processing.

    After removal of rRNA and adapter sequences as well as some trimming and removal of low quality reads the fastqc stats look like this.


    I'd appreciate any (useful) comments.
    Best regards,
    Tim

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Working...